Dextropropoxyphene napsylate

Dextropropoxyphene napsylate is an active ingredient that is used in some medicines.

The active ingredient is the chemical in a medicine that makes it work. Medicines can have more than one active ingredient and be available under different brand names. Medicines include both active ingredients and inactive ingredients.

This page about dextropropoxyphene napsylate automatically lists related information collected from other pages of our website.

The list below also includes links to brands of medicines that contain dextropropoxyphene napsylate, including their consumer medicine information (CMI) leaflets.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - dextropropoxyphene napsylate

Audience:
       

(Medicine)
11 Dec 2014 Doloxene Capsules is a brand of medicine. Find out about side effects, who can and who shouldn’t use Doloxene Capsules by reading the latest Australian consumer medicine information. See our tips on how to use medicines wisely and safely.
(Topic)
06 Nov 2013 Find out about pain relievers containing dextroproproxyphene (e.g. Di-Gesic and Doloxene) and how the new prescribing and supply processes might affect you.
For health professionals (Health professional publication)
14 Oct 2013 Dextropropoxyphene-containing analgesics Di-Gesic and Doloxene will remain registered subject to new conditions.
(Media release)
02 Mar 2012 NPS has published information online for prescribers to help them prepare for the TGA's cancellation of Capadex and Paradex, two of the four medicines available in Australia containing dextropropoxyphene
(Media release)
22 Feb 2012 NPS issued a media release late last year supporting the TGA's decision to cancel four prescription pain relief medicines containing dextropropoxyphene from 1 March 2012.
(Media release)
24 Nov 2011 NPS has applauded the TGA's decision to cancel four prescription pain relief medicines containing dextropropoxyphene from 1 March 2012.

Medicine brands that contain dextropropoxyphene napsylate